Recently certain molecular regulators of microglial proliferation have been directly demonstrated to exist including triggering receptor expressed on myeloid cells 2 (TREM2) and apolipoprotein E (APOE) which are both among AD risk factors for Late Onset AD (LOAD) (Wolfe et al., 2018). The gene discussed is TREM2; the disease is Alzheimer disease.